CLINICAL STUDY ON AMAVATA WITH SPECIAL REFERENCE TO JUVENILE RHEUMATOID ARTHRITIS BY PIPPALI VARDHAMANA RASAYANA
Dr. Singh Shardul Vikram*, Dr. Mahendra Singh, Dr. Richa Singh, Dr. Ishwar Chandra Rai , Dr. M. Kavitha Dr. Ranjan Rohit
ABSTRACT
Amavata is a very distressing disease among joint disorders. It occurs
throughout the world but higher proportions of patients are seen in
urban areas, and predominant in female compared to male. It is a
debilitating disease in view of its chronicity and complications
therefore it has taken the foremost place among the joint disorders. The
most common disease involving joints in children is Rheumatoid
Arthritis. The rheumatoid arthritis in children below 16 years is
prefixed with the term Juvenile hence known as Juvenile Rheumatoid
Arthritis by American Rheumatism Association. This study includes
evaluating the efficacy of trial drugs Pippali Vardhamana Rasayana
and Rasna saptak kashaya in the management of Amavata. Amavata is a challenging and
burning disease for the physicians and medical field. Amavata can be compared with
rheumatoid arthritis due to its similarity in clinical picture mentioned in Ayurvedic classics.
As the etiopathogenesis of the disease mentioned in texts is obvious hence the Ayurvedic
treatment is also specific and effective. However, till today no satisfactory modern medical
management has been developed for these problems. A lot of study has been taken place in
the past few decades to liberate human kind from the tremendous agony which one faces in
this disease. In Ayurvedic classics also many treatment modalities like Shodhana and Shamana Chikitsa are mentioned. Here in this study specifically focused on Samprapti
Vighatanatmak Chikitsa. The drug Pippali Vardhamana Rasayana and Rasna Saptak
Kashaya are chosen to evaluate its efficacy in the disease Amavata.
Keywords: Amavata, Juvenile Rheumatoid Arthritis, Pippali Vardhamana Rasayana, Rasna saptak kashaya.
[Download Article]
[Download Certifiate]